{
    "startDate": "2021-01-01",
    "endDate": "2021-03-31",
    "year": "2021",
    "quarter": "Q1",
    "symbol": "SLNO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 41607000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 921000
            },
            {
                "label": "Current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 42528000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 20000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 50000
            },
            {
                "label": "Finance lease right-of-use assets",
                "concept": "FinanceLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 13000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 14095000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 56706000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 4669000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 411000
            },
            {
                "label": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to clinical trial services received from vendors, such as accrued contract research organization costs, patient costs, clinical site costs and clinical product cost. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                "concept": "slno:AccruedClinicalTrialCostsCurrent",
                "unit": "usd",
                "value": 4140000
            },
            {
                "label": "Operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 57000
            },
            {
                "label": "Other current liabilities",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 232000
            },
            {
                "label": "Current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 9509000
            },
            {
                "label": "Asset acquisition contingent consideration liability noncurrent.",
                "concept": "slno:AssetAcquisitionContingentConsiderationLiabilityNoncurrent",
                "unit": "usd",
                "value": 9291000
            },
            {
                "label": "Liabilities and stockholders\u2019 equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 19138000
            },
            {
                "label": "Commitments and contingencies (Note 6)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value, 250,000,000 shares authorized, 79,723,680 and 79,615,692 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively.",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 80000
            },
            {
                "label": "Additional paid-in-capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 228887000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -191399000
            },
            {
                "label": "Stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 37568000
            },
            {
                "label": "Liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 56706000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -8954000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 489000
            },
            {
                "label": "Noncash lease expense.",
                "concept": "slno:NoncashLeaseExpense",
                "unit": "usd",
                "value": 76000
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1095000
            },
            {
                "label": "Change in fair value of warrants liabilities",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -201000
            },
            {
                "label": "Asset acquisition contingent consideration change in fair value.",
                "concept": "slno:AssetAcquisitionContingentConsiderationChangeInFairValue",
                "unit": "usd",
                "value": -987000
            },
            {
                "label": "Prepaid expenses, other current assets and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -98000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 1180000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -594000
            },
            {
                "label": "Increase decrease in accrued clinical trial site costs.",
                "concept": "slno:IncreaseDecreaseInAccruedClinicalTrialSiteCosts",
                "unit": "usd",
                "value": 351000
            },
            {
                "label": "Increase decrease in operating lease liabilities.",
                "concept": "slno:IncreaseDecreaseInOperatingLeaseLiabilities",
                "unit": "usd",
                "value": -82000
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": 41000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -7488000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -4000
            },
            {
                "label": "Tax withholding payments for net share-settled equity awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 120000
            },
            {
                "label": "Principal paid on finance lease liabilities",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": 5000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -125000
            },
            {
                "label": "Net decrease in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -7617000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 7164000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2979000
            },
            {
                "label": "Asset acquisition contingent consideration change in fair value.",
                "concept": "slno:AssetAcquisitionContingentConsiderationChangeInFairValue",
                "unit": "usd",
                "value": -987000
            },
            {
                "label": "Operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 9156000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -9156000
            },
            {
                "label": "Interest income",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Other income",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 202000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -8954000
            },
            {
                "label": "Net loss per common share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.11
            },
            {
                "label": "Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 79694781
            }
        ]
    }
}